Scientific Advances and New Frontiers in Mesothelioma Therapeutics-Reference-Cited by-同舟云学术

Scientific Advances and New Frontiers in Mesothelioma Therapeutics

Published:2018-09 Issue:9 Volume:13 Page:1269-1283
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Mutti Luciano,Peikert Tobias,Robinson Bruce W.S.,Scherpereel Arnaud,Tsao Anne S.,de Perrot Marc,Woodard Gavitt A.,Jablons David M.,Wiens Jacinta,Hirsch Fred R.,Yang Haining,Carbone Michele,Thomas Anish,Hassan Raffit

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference132 articles.

1. Malignant pleural mesothelioma: a comprehensive review;Ismail-Khan;Cancer Control,2006

2. Malignant mesothelioma of the tunica vaginalis: a rare neoplasm–case report and literature review;Segura-Gonzalez;Clin Genitourin Cancer,2015

3. Mesothelioma not associated with asbestos exposure;Jasani;Arch Pathol Lab Med,2012

4. Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic;Roe;Eur Respir Rev,2015

5. Simian virus 40 and human tumors: it is time to study mechanisms;Carbone;J Cell Biochem,1999

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thonzonium bromide inhibits progression of malignant pleural mesothelioma through regulation of ERK1/2 and p38 pathways and mitochondrial uncoupling;Cancer Cell International;2024-06-29

2. Global burden of mesothelioma attributable to occupational asbestos exposure in 204 countries and territories: 1990–2019;Journal of Cancer Research and Clinical Oncology;2024-05-28

3. Pleural mesothelioma in situ: a comprehensive review;European Journal of Cancer Prevention;2024-03-11

4. Antipodoplanin antibody enhances the antitumor effects of CTLA‐4 blockade against malignant mesothelioma by natural killer cells;Cancer Science;2023-12-26

5. Pleural Mesothelioma: Treatable Traits of a Heterogeneous Disease;Cancers;2023-12-06